Etanercept Pen

Etanercept Pen

Form: Pre-filled Syringe or Pen

Strength: 50 mg/0.5 mL, 50 mg/1 mL

Reference Brands: Enbrel (US & EU)

Category: Arthritis

Etanercept pen is approved in the EU and US for the treatment of rheumatoid arthritis and other autoimmune diseases. In the EU, brands like Enbrel are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate efficient market access for etanercept pens, ensuring adherence to European and US standards for safe, effective biologic therapy and navigating complex regulatory frameworks seamlessly.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Pegloticase injecatble

Strength: 8 mg/1.2 mL vial

Form: Injectable (IV solution)

Reference Brands: Krystexxa (US)

View Details Get Enquiry
Colchicine tablest

Strength: 0.6 mg

Form: Tablet

Reference Brands: Colcrys(US)

View Details Get Enquiry
Febuxostat tablets

Strength: 40 mg, 80 mg

Form: Oral Tablets

Reference Brands: Uloric(EU & US)

View Details Get Enquiry
Allopurinol tablets

Strength: 100 mg, 300 mg

Form: Oral Tablets

Reference Brands: Aloprim(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.